Commentary

REFERENCES

1. Menon G. J., Rahman I, Menon S. J., Dutton D. G., . Complex visual hallucinations in the visually impaired: The Charles Bonnet syndrome. Surv Ophthalmol. 2003;48:58-72.

   [Google Scholar]
2. Teunisse R. J., Cruysberg J. R., Hoefnagels W. H., Verbeek A. L., Zitman F. G., . Visual hallucinations in psychologically normal people: Charles Bonnet’s syndrome. Lancet. 1996;347:794-7.

   [Google Scholar]
3. Schadlu A. P., Schadlu R, Shephard J. B., . 3rd. Charles Bonnet syndrome: A review. Curr Opin Ophthalmol. 2009;20:219-22.

   [Google Scholar]
4. Issa B. A., Yussuf A. D., . Charles bonnet syndrome, management with simple behavioral technique. J Neurosci Rural Pract. 2013;4:63-5.

   [Google Scholar]
5. Vukicevic M, Fitzmaurice K, . Butterflies and black lacy patterns: The prevalence and characteristics of Charles Bonnet hallucinations in an Australian population. Clin Experiment Ophthalmol. 2008;36:659-65.

   [Google Scholar]
6. Meyer C. H., Mennel S, Hörle S, Schmidt J. C., . Visual hallucinations after intravitreal injection of bevacizumab in vascular age-related macular degeneration. Am J Ophthalmol. 2007;143:169-70.

   [Google Scholar]
7. Singh A, Sorensen T. L., . The prevalence and clinical characteristics of Charles Bonnet Syndrome in Danish patients with neovascular age-related macular degeneration. Acta Ophthalmol. 2010;90:476-80.

   [Google Scholar]
8. Singh A, Sorensen T. L., . Charles Bonnet syndrome improves when treatment is effective in age-related macular degeneration. Br J Ophthalmol. 2011;95:291-2.

   [Google Scholar]
9. Hartney K. E., Catalano G, Caralano M. C., . Charles Bonnet syndrome: Are medications necessary? J Psychiatr Pract. 2011;17:137-41.

   [Google Scholar]